---
title: Medical Student Quick Topics
author: J. Austin Straley, DO
date: 2023-02-28
layout: medstudentsalone
category: projects
published: true
permalink: /msqt
lesson: 6
importance: 1
---

<link rel="stylesheet" href="{{site.baseurl}}/assets/project-style.css">

# Medical Student Readings
- M3/M4 Suggested Articles
    - [SIU Reading List](https://www.med.unc.edu/medclerk/wp-content/uploads/sites/877/2018/10/SIUreadinglist.pdf){:target="_blank"}
    - [UNC Suggested Reading](https://www.med.unc.edu/medclerk/resources/suggested-reading-topics/){:target="_blank"}
- [M4 ED Curriculum](https://www.saem.org/about-saem/academies-interest-groups-affiliates2/cdem/for-students/online-education/m4-curriculum){:target="_blank"}
    - [Incomplete ER Journal Club Articles](https://wikem.org/wiki/Category:Incomplete_Journal_Club_Articles){:target="_blank"}
- Trial Pages
    - [Wiki Journal Club](https://www.wikijournalclub.org/wiki/Main_Page){:target="_blank"}
    - [2 Minute Medicine - The Classics - Summaries](https://www.2minutemedicine.com/the-classics-in-medicine-summaries-of-the-landmark-trials/){:target="_blank"}
    - [2 Minute Medicine - The Classics - Directory](https://www.2minutemedicine.com/the-classics-directory/){:target="_blank"} 
- [ICU Guide UOC](http://chicago.medicine.uic.edu/wp-content/uploads/sites/6/2017/09/icuguidebook.pdf){:target="_blank"} 
- [Bugs & Drugs](https://www.bugsanddrugs.org/){:target="_blank"} 
- [Tulane Pharmacy School Website](https://tmedweb.tulane.edu/pharmwiki/doku.php/start){:target="_blank"} 
- Drug Interaction Books
    - [Louisville Interactions - Adults](https://kdpnet.kdp.louisville.edu/drugbook/adult/?node=4547){:target="_blank"} 
    - [Louisville Interactions](https://kdpnet.kdp.louisville.edu/){:target="_blank"} 
- [EKG Practice](https://ecg.bidmc.harvard.edu/maven/mavenmain.asp){:target="_blank"} 
- Arrythmia Databases
    - [Physionet](https://physionet.org/content/mitdb/1.0.0/){:target="_blank"} 
    - [Physionet Database](https://archive.physionet.org/physiobank/database/html/mitdbdir/mitdbdir.htm){:target="_blank"} 

<br>

# Cardiology

- [Atrial Fibrillation](https://www.ncbi.nlm.nih.gov/books/NBK526072/){:target="_blank"}
    - [Management](https://pubmed.ncbi.nlm.nih.gov/30144419/){:target="_blank"}
        - [AFFIRM: Rate-control = Rhythm-control; Rate preferred due to Adverse events](https://pubmed.ncbi.nlm.nih.gov/12466506/){:target="_blank"}
        - [RACE-II: Lenient non-inferior to strict rate-control in afib](https://pubmed.ncbi.nlm.nih.gov/20231232/){:target="_blank"}
        - [RAAFT-2: RFA if AAD failed as 1st line for symptomatic PAF](https://pubmed.ncbi.nlm.nih.gov/24549549/){:target="_blank"}
        - [AVERROES: Eliquis > Aspirin for Stroke/VTE](https://pubmed.ncbi.nlm.nih.gov/21309657/){:target="_blank"}
        - [ARISTOTLE: Eliquis > Warfarin for stroke, less brain bleeding](https://pubmed.ncbi.nlm.nih.gov/21870978/){:target="_blank"}
        - [ROCKET-AF: Xarelto is non-inferior to Warfarin](https://pubmed.ncbi.nlm.nih.gov/21830957/){:target="_blank"}
        - [BRIDGE: Periprocedural bridging did not reduce ATE, increased bleeding](https://pubmed.ncbi.nlm.nih.gov/26095867/){:target="_blank"}
- Coronary Artery Disease (CAD)
    - Management
        - [4S: Statins reduce Death, MI, Revasc in Angina/MI patients](https://pubmed.ncbi.nlm.nih.gov/7968073/){:target="_blank"}
        - [SATURN: Crestor better LDL reduction, no better mortality than Lipitor](https://pubmed.ncbi.nlm.nih.gov/22085316/){:target="_blank"}
        - [COURAGE: PCI w/BMS in Stable CAD non-superior to medical therapy](https://pubmed.ncbi.nlm.nih.gov/17387127/){:target="_blank"}
        - [In life expectancy <1, discontinuation of statin did not increase 60-day mortality](https://pubmed.ncbi.nlm.nih.gov/20818875/){:target="_blank"}
- Chest Pain/Angina Pectoris
    - [Diagnosis](https://pubmed.ncbi.nlm.nih.gov/34756653/){:target="_blank"}
    - [Chest Pain in the ED (M4s)](https://www.saem.org/about-saem/academies-interest-groups-affiliates2/cdem/for-students/online-education/m4-curriculum/group-m4-approach-to/chest-pain){:target="_blank"}
    - [HEART vs. TIMI vs. GRACE](https://www.internationaljournalofcardiology.com/article/S0167-5273(16)33282-X/fulltext){:target="_blank"}
- Heart Failure 
    - [Physiology](https://derangedphysiology.com/main/cicm-primary-exam/required-reading/cardiovascular-system){:target="_blank"}
    - [Risk Assessment](https://pubmed.ncbi.nlm.nih.gov/31526538/){:target="_blank"} 
    - Management 
        - [Guidelines](https://pubmed.ncbi.nlm.nih.gov/35379504/){:target="_blank"}
        - [University of Michigan Guide](https://www.ncbi.nlm.nih.gov/books/NBK589894/){:target="_blank"}
        - [ED Management of Acute Heart Failure](https://emergencymedicinecases.com/acute-heart-failure-management-pocus-oxygenation-ppv-havoc-scape/){:target="_blank"} 
        - [Prognostic Biomarkers in the ED in HF](https://thoracickey.com/diagnostic-and-prognostic-biomarkers-in-emergency-department-heart-failure/){:target="_blank"}
        - Diuretics
            - [Diuretic Therapy for HF (JACC State-of-the-Art Review)](https://pubmed.ncbi.nlm.nih.gov/32164892/){:target="_blank"}
                - [JACC Diuretic Therapy](https://www.jacc.org/doi/10.1016/j.jacc.2019.12.059){:target="_blank"}
            - [Physiology of Diuretics in Acute Heart Failure](https://pubmed.ncbi.nlm.nih.gov/32164892/){:target="_blank"}
            - [DOSE-AHF: High-dose loops > symptom improvement; intermittent = continuous](https://pubmed.ncbi.nlm.nih.gov/21366472/){:target="_blank"}
            - [Optimal Diuretic Strategies in HF](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039650/){:target="_blank"}
        - GDMT
            - [ACEI in Asymptomatic LV dysfunction](https://pubmed.ncbi.nlm.nih.gov/1463530/){:target="_blank"}
            - [REVERT: BBs Reverse LV remodeling in asymptomatic LV systolic dysfunction](https://pubmed.ncbi.nlm.nih.gov/17576868/){:target="_blank"}
            - [PARADIGM-HF: Entresto reduced CV risk and Hospitalizations vs. ACEI](https://pubmed.ncbi.nlm.nih.gov/25176015/){:target="_blank"}
            - MRAs
                - [Eplerenone in patients with HF and mild symptoms](https://pubmed.ncbi.nlm.nih.gov/21073363/){:target="_blank"}
                - [RALES: Spironolactone reduces morbidity/mortality in severe HFrEF](https://pubmed.ncbi.nlm.nih.gov/10471456/){:target="_blank"}
            - [SGLT2 better than Sitagliptin (Primary outcome: 13.1% vs. 17.4)](https://academic.oup.com/eurheartj/article/44/24/2216/7187574){:target="_blank"}
            - [STRONG-HF: Rapid up-titration of GDMT and close f/u reduced risk of 180-day all-cause death or HF readmission in AECHF admits](https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2022/12/05/14/33/strong-hf){:target="_blank"}  
                - [European Heart Journal](https://academic.oup.com/eurheartj/article/44/31/2947/7175273){:target="_blank"}
            - [Persistent Severe HF symptoms on maximal GDMT](https://pubmed.ncbi.nlm.nih.gov/32216916/){:target="_blank"}
        - Inotropes
            - [Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controlled study](https://pubmed.ncbi.nlm.nih.gov/12939113/){:target="_blank"}
            - [Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial](https://pubmed.ncbi.nlm.nih.gov/11911756/){:target="_blank"}
        - [FAIR-HF: Anemia (ferritin <100, or 100-300 w/Tsat <20%) + HFrEF (EF â‰¤45%) improved 6m walk, QOL and NYHA functional Class](https://pubmed.ncbi.nlm.nih.gov/19920054/){:target="_blank"}
        - Exercise training/cardiac rehabilitation 
            - [Improves functional capacity and overall quality of life](https://pubmed.ncbi.nlm.nih.gov/25605639/){:target="_blank"}
            - [QOL](https://pubmed.ncbi.nlm.nih.gov/25399909/){:target="_blank"}
        - [Chronic Stable HF Optimization](https://pubmed.ncbi.nlm.nih.gov/29277252/){:target="_blank"}
- Hyperlipidemia
    - [Management](https://pubmed.ncbi.nlm.nih.gov/30586774/){:target="_blank"}
- Hypertension
    - [Management](https://pubmed.ncbi.nlm.nih.gov/29146535/){:target="_blank"}
        - [DASH: Small but significant BP reductions from diet control](http://www.ncbi.nlm.nih.gov/pubmed/9099655){:target="_blank"}
        - [LIFE: Losartan > Atenolol for same BP Reduction](https://pubmed.ncbi.nlm.nih.gov/11937179/){:target="_blank"}
        - [ALLHAT: Thiazide = CCB = ACEI in High-risk HTN, Thiazides may be better](https://pubmed.ncbi.nlm.nih.gov/12479763/){:target="_blank"}
        - [ACCOMPLISH: CCBs > Diuretics when added to ACEI in High-risk HTN](https://pubmed.ncbi.nlm.nih.gov/19052124/){:target="_blank"}
        - [Thiazides less effective in obese, CCBs equal across weight](https://pubmed.ncbi.nlm.nih.gov/23219284/){:target="_blank"}
        - [HOPE: ACEI significantly reduces rate of HF in High-risk patients](https://pubmed.ncbi.nlm.nih.gov/12628949/){:target="_blank"}
        - [Asymptomatic Inpatient Hypertension](https://pubmed.ncbi.nlm.nih.gov/30811320/){:target="_blank"}
        - [Things We Do For No Reason: Antihypertensives Inpatient](https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.13185){:target="_blank"}
        - [Hydralazine vs. Labetalol Inpatient](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673377/){:target="_blank"}
    - [Resistant Hypertension](https://pubmed.ncbi.nlm.nih.gov/27895136/){:target="_blank"}
- Myocardial Infarction
    - [Definition](https://pubmed.ncbi.nlm.nih.gov/30153967/){:target="_blank"}
    - Management
        - [PLATO: Ticagrelor > Clopidogrel in ACS including mortality](http://www.ncbi.nlm.nih.gov/pubmed/19717846){:target="_blank"}
        - [PROVE-IT: Significantly reduced CVD events following MI with High-dose Lipitor vs. Pravastatin](http://www.ncbi.nlm.nih.gov/pubmed/15007110){:target="_blank"}
        - [SAVE: ACEI improve survival/morbidity/mortality in LV dysfunction after MI](https://pubmed.ncbi.nlm.nih.gov/1386652/){:target="_blank"}
        - [DAPT: Continuing Thienopyridine after 12 months decreased risk of In-stent thrombosis and MI at 18 months, increased risk of bleeding](https://pubmed.ncbi.nlm.nih.gov/25399658/){:target="_blank"}
        - [WOEST: Bleeding w/AC + Plavix < Triple Therapy w/o change in MI/Stroke/MACE](https://pubmed.ncbi.nlm.nih.gov/23415013/){:target="_blank"}
        - [COGENT: PPI with DAPT reduces GIB 87%, no CV event change](https://pubmed.ncbi.nlm.nih.gov/20925534/){:target="_blank"}
        - [MADIT-II: ICD improves survival in pts with prior MI and severe LV dysfunction](https://pubmed.ncbi.nlm.nih.gov/11907286/){:target="_blank"}
- Syncope
    - [Incidence and Prognosis](https://pubmed.ncbi.nlm.nih.gov/12239256/){:target="_blank"}
    - [Diagnosis and Management](https://pubmed.ncbi.nlm.nih.gov/19713422/){:target="_blank"}
    - [Diagnosis and Management](https://pubmed.ncbi.nlm.nih.gov/28280232/){:target="_blank"}

<br>

# Dermatology
- Cutaneous Tumors

<br>

# Endocrinology
- Diabetes Mellitus
- Hypothyroidism
- Hyperthyroidism
- Hypercalcemia

<br>

# Gastroenterology (GI)
- GERD
- PUD
- Cholelithiasis
- Viral hepatitis
- Colon polyps/Cacner
- Jaundice
- GI bleeding

<br>

# General
- Alcohol Use/Drug Use
- Preventive Health Care

<br>

# Geriatrics
- Normal Aging
-  Delirium/Dementia

<br>

# Hematology
- Iron Deficiency Anemia
- Anemia of Chronic Disease
- Lymphomas
- DIC
- Thrombocytopenia
- Chronic Leukemia

<br>

# Infectious Disease
- Cellulitis
- Pneumonia
- Bronchitis
- UTI
- AIDS
- Septic Shock

<br>

# Nephrology
- Acute Renal Failure
- Fluids/Electrolytes

<br>

# Oncology
- Breast Cancer

<br>

# Pulmonology
- Acute Respiratory Failure
- Asthma
- COPD
- Interstitial Lung Disease (ILD) 
- Lung Cancer
- PE/DVT
- Pleural Effusion
    - Management
        - [Management of infectious processes of the pleural space: a review](https://pubmed.ncbi.nlm.nih.gov/22536502/){:target="_blank"}
- Sleep Apnea

<br>

# Rheumatology
- Septic Arthritis
- RA
- OA
- SLE
- Gout
- Ankylosing Spondylitis
- Polymyalgia Rheumatica

<br>